Guerbet have joined the BIR as a corporate subscriber. Guerbet produces contrast agents and offers medical devices and injectors from partner companies for use in the medical imaging market.
The BIR now has 23 corporate subscribers who benefit from membership of the BIR.
BIR corporate subscribers are encouraged to join BIR special interest groups, to collaborate in developing educational events and to get involved with publishing activities.
Jacqueline Fowler, Chief Executive of the BIR said, “It is a pleasure to have Guerbet on board as a corporate subscriber. We welcome their involvement and look forward to seeing Guerbet not only at our events but getting involved with our special interest groups.”
Image: General Manager, Levi Cheng with BIR Chief Executive Jacqueline Fowler.
